Tohoku J. Exp. Med., 2010, 222(1)

The -765C Allele of the Cyclooxygenase-2 Gene as a Potential Risk Factor of Colorectal Cancer: A Meta-Analysis

HUI CAO,1 ZHONG XU,2 HAO LONG,1 XIAO-QING LI1 and SHAO-LIN LI1

1Department of Radiation Medicine, Chongqing Medical University, Chongqing, PR China
2Department of Gastroenterology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, PR China

Colorectal cancer (CRC) is the third leading cause of cancer-related death in the world. Human colorectal carcinogenesis is a complex, multistep and multigenetic process. Cyclooxygenase-2 (COX2), a key enzyme in arachidonic acid metabolism, is overexpressed in several epithelial malignancies including colorectal cancer. COX2 expression can be induced by pro-inflammatory and mitogenic stimuli. The -765G/C polymorphism of the COX2 gene promoter has been reported to affect CRC susceptibility, but recent studies have demonstrated conflicting results. To shed light on these inconclusive findings, we performed a meta-analysis for assessing the involvement of COX2 -765G/C polymorphisms at the onset of colorectal carcinoma. Literature-based searching was guided to gather data and either fixed-effect or random-effect model was used to pool the odds ratio (OR) according to the test of heterogeneity. The 10 eligible case-control studies included 3,322 colorectal cancer cases and 5,166 controls. Overall, no evidence has indicated that individuals carrying GC+CC genotypes had significantly increased colorectal cancer risk compared with GG genotype [OR = 1.06, 95% confidence interval (95% CI) = 0.94-1.20]. However, stratified analysis with ethnicity indicated that individuals carrying GC+CC genotypes had an increased risk of colorectal cancer (OR = 1.40, 95% CI = 1.11-1.76) among Asian population. In conclusion, although not all bias could be eliminated, the -765C allele of the COX2 gene may be a potential risk factor for colorectal cancer in Asians.

keywords —— colorectal neoplasm; susceptibility; COX2; gene polymorphism; meta-analysis

===============================

Tohoku J. Exp. Med., 2010, 222, 15-21

Correspondence: Shao-lin Li, Department of Radiation Medicine, Chongqing Medical University, Chongqing 400016, PR China.

e-mail: lishaolin@cqmu.edu.cn